These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 21614412

  • 1. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A, Lenglet S, Chaurand P, Deglon J, Mangin P, Mach F, Steffens S, Wolfender JL, Staub C.
    Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Computational biology for cardiovascular biomarker discovery.
    Azuaje F, Devaux Y, Wagner D.
    Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The emerging role of plasma lipidomics in cardiovascular drug discovery.
    Puri R, Duong M, Uno K, Kataoka Y, Nicholls SJ.
    Expert Opin Drug Discov; 2012 Jan; 7(1):63-72. PubMed ID: 22468894
    [Abstract] [Full Text] [Related]

  • 7. Recent developments in tandem mass spectrometry for lipidomic analysis.
    Zehethofer N, Pinto DM.
    Anal Chim Acta; 2008 Oct 03; 627(1):62-70. PubMed ID: 18790128
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS, Jakubowski N.
    Chem Soc Rev; 2009 Jul 03; 38(7):1969-83. PubMed ID: 19551177
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B, Ball G, Rees R.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Contribution of proteomic analysis to study cardiovascular physiopathology].
    Dupont A, Pinet F.
    Ann Biol Clin (Paris); 2005 Sep 27; 63(6):611-7. PubMed ID: 16330379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE, Lane L.
    Expert Rev Proteomics; 2014 Jun 27; 11(3):269-84. PubMed ID: 24720436
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR, Liotta LA, Petricoin EF.
    Biosci Rep; 2005 Jun 27; 25(1-2):107-25. PubMed ID: 16222423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.